Patients suffering from incurable diseases are more likely to die in the hospital than at home. Specialized outpatient palliative care (PC) may be able to counteract this tendency. Similarly, potential benefits of telemedicine in health care were scientifically reported. The aim of this research was to compare patients receiving specialized outpatient PC plus telemedicine with those receiving standard specialized outpatient PC only. In this study, telemedicine is assumed to decrease the number of home visits and therefore should not be considered a mere add-on.
Methods:
This is a randomized controlled noninferiority trial. Recruitment lasted between January 2020 and October 2021. Quality of care was evaluated using the Integrated Palliative Care Outcome Scale (IPOS) at day 0, 7, and 14 after randomization. Change from day 0 to 7 was defined as the primary outcome (noninferiority margin = 4 points). This study was conducted in an urban setting in collaboration with a university hospital and a local specialized outpatient PC service.
Results:
A total of 196 patients were screened with 34 patients included (18 telemedicine/16 standard care). The mean change in the total score of the IPOS from day 0 to 7 amounted to −1.8 ± 3.9 (telemedicine) versus 1.2 ± 5.7 (standard care). The telemedicine group was statistically not relevantly inferior to the standard care group (t-test for noninferiority, p = 0.005).
Conclusions:
Although, due to COVID-19, the sample size remained rather small, our findings indicate that telemedical approaches offer a promising and equally effective option to provide specialized outpatient PC.
Clinical Trial Registration Number: NCT06054048.
Get full access to this article
View all access options for this article.
References
1.
KazazianK, NgD, SwallowCJ. Impact of the coronavirus disease 2019 pandemic on delivery of and models for supportive and palliative care for oncology patients. Curr Opin Support Palliat Care, 2022; 16(3):130–137; doi: 10.1097/spc.0000000000000606
2.
RitcheyKC, FoyA, McArdelE, et al.Reinventing palliative care delivery in the era of COVID-19: How telemedicine can support end of life care. Am J Hosp Palliat Care, 2020; 37(11):992–997.
3.
SirintrapunSJ, LopezAM. Telemedicine in CancerCare. In: American Society of Clinical Oncology EducationalBook. American Society of ClinicalOncology. AnnualMeeting. Vol. 38. 2018; pp. 540–545.
4.
WorsterB, SwartzK. Telemedicine and palliative care: An increasing role in supportive oncology. Curr Oncol Rep, 2017; 19(6):37.
5.
SteindalSA, NesAAG, GodskesenTE, et al.Patients' experiences of telehealth in palliative home care: Scoping review. J Med Internet Res, 2020; 22(5):e16218; doi: 10.2196/16218
6.
Slavin-StewartC, PhillipsA, HortonR. A feasibility study of home-based palliative care telemedicine in Rural Nova Scotia. J Palliat Med, 2020; 23(4):548–551; doi: 10.1089/jpm.2019.0173
7.
Read PaulL, SalmonC, SinnarajahA, et al.Web-based videoconferencing for rural palliative care consultation with elderly patients at home. Support Care Cancer, 2019; 27(9):3321–3330; doi: 10.1007/s00520-018-4580-8
8.
Allen WattsK, MaloneE, Dionne-OdomJN, et al.Can you hear me now?: Improving palliative care access through telehealth. Res Nurs Health, 2021; 44(1):226–237; doi: 10.1002/nur.22105
9.
World Health Organization. World Health Organization Definition of Palliative Care. 2002. Available from: https://www.who.int/cancer/palliative/definition/en/ [Last accessed: June28, 2022].
10.
KamalAH, BauseweinC, CasarettDJ, et al.Standards, guidelines, and quality measures for successful specialty palliative care integration into oncology: Current approaches and future directions. J Clin Oncol, 2020; 38(9):987–994.
11.
HuiD, BrueraE. Models of palliative care delivery for patients with cancer. J Clin Oncol, 2020; 38(9):852–865.
12.
PrützF, SaßAC. [Data on palliative care in Germany: Which data sources are available and what do they tell?]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz, 2017; 60(1):26–36; doi: 10.1007/s00103-016-2483-8
13.
HessS, StielS, HofmannS, et al.Trends in specialized palliative care for non-cancer patients in Germany—Data from the national hospice and palliative care evaluation (HOPE). Eur J Intern Med, 2014; 25(2):187–192; doi: 10.1016/j.ejim.2013.11.012
14.
KirkovaJ, WalshD, RybickiL, et al.Symptom severity and distress in advanced cancer. Palliat Med, 2010; 24(3):330–339; doi: 10.1177/0269216309356380
15.
BauseweinC, DavesonBA, CurrowDC, et al.EAPC White Paper on outcome measurement in palliative care: Improving practice, attaining outcomes and delivering quality services—Recommendations from the European Association for Palliative Care (EAPC) Task Force on Outcome Measurement. Palliat Med, 2016; 30(1):6–22; doi: 10.1177/0269216315589898
16.
SeippH, HaasenritterJ, HachM, et al.State-wide implementation of patient-reported outcome measures (PROMs) in specialized outpatient palliative care teams (ELSAH): A mixed-methods evaluation and implications for their sustainable use. BMC Palliat Care, 2022; 21(1):216; doi: 10.1186/s12904-022-01109-w
17.
BajwahS, OluyaseAO, YiD, et al.The effectiveness and cost-effectiveness of hospital-based specialist palliative care for adults with advanced illness and their caregivers. Cochrane Database Syst Rev, 2020; 9(9):Cd012780; doi: 10.1002/14651858.CD012780.pub2
18.
SmithS, BrickA, O'HaraS, et al.Evidence on the cost and cost-effectiveness of palliative care: A literature review. Palliat Med, 2014; 28(2):130–150; doi: 10.1177/0269216313493466
19.
TemelJS, GreerJA, MuzikanskyA, et al.Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med, 2010; 363(8):733–742; doi: 10.1056/NEJMoa1000678
20.
FöllmerJ.Palliative care in statutory health insurance: On hospice care according to § 39a SGB V and specialized outpatient palliative care according to § 37b SGB V. Springer-Verlag; 2013.
21.
LoosenSH, KriegS, EschrichJ, et al.The landscape of outpatient palliative care in Germany: Results from a retrospective analysis of 14,792 patients. Int J Environ Res Public Health, 2022; 19(22):14885; doi: 10.3390/ijerph192214885
22.
NauckF, JanskyM. [Palliative home care teams in Germany]. Dtsch Med Wochenschr, 2018; 143(8):558–565; doi: 10.1055/s-0043-115628
23.
DitscheidB, KrauseM, LehmannT, et al.[Palliative care at the end of life in Germany: Utilization and regional distribution]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz, 2020; 63(12):1502–1510; doi: 10.1007/s00103-020-03240-6
24.
WillingerA, HemmerlingM, StahmeyerJT, et al.The frequency and time point of outpatient palliative care integration for people before death: An analysis of health insurance data in Lower Saxony, Germany. J Public Health, 2023; 31(8):1351–1359.
25.
van BaalK, SchraderS, SchneiderN, et al.Quality indicators for the evaluation of end-of-life care in Germany—A retrospective cross-sectional analysis of statutory health insurance data. BMC Palliat Care, 2020; 19(1):187; doi: 10.1186/s12904-020-00679-x
26.
DaschB, BlumK, BauseweinC. [Estimation of the palliative care needs and the extent of coverage by specialized outpatient palliative care teams in selected regions of Westphalia-Lippe]. Gesundheitswesen, 2017; 79(12):1036–1042; doi: 10.1055/s-0041-110529
27.
HoffmannTC, GlasziouPP, BoutronI, et al.Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide. BMJ, 2014; 348:g1687; doi: 10.1136/bmj.g1687
28.
SchulzKF, AltmanDG, MoherD. CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials. J Pharmacol Pharmacother, 2010; 1(2):100–107.
29.
HearnJ, HigginsonI. Development and validation of a core outcome measure for palliative care: The palliative care outcome scale. Palliative Care Core Audit Project Advisory Group. Qual Health Care, 1999; 8(4):219–227.
30.
MurtaghFE, RamsenthalerC, FirthA, et al.A brief, patient-and proxy-reported outcome measure in advanced illness: Validity, reliability and responsiveness of the Integrated Palliative care Outcome Scale (IPOS). Palliat Med, 2019; 33(8):1045–1057.
31.
WellekS, BlettnerM. Establishing equivalence or non-inferiority in clinical trials: Part 20 of a series on evaluation of scientific publications. Deutsches Arzteblatt Int, 2012; 109(41):674–679.
32.
Points to consider on switching between superiority and non-inferiority. Br J Clin Pharmacol, 2001;52(3):223–228; doi: 10.1046/j.0306-5251.2001.01397-3.x
33.
SpickermannM, LenzP. Evaluation of an inpatient palliative care service using the Integrated Palliative Care Outcome Scale (IPOS) is Feasible: A Prospective Observational Study. EAPC Abstracts. Palliat Med, 2019; 33(1):118–589; doi: 10.1177/0269216319844405
34.
R Core Team. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing: Vienna, Austria; 2016. Available from: https://www.r-project.org [Last accessed: December3, 2023].
35.
WassmerG, PahlkeF. rpact: Confirmatory Adaptive Clinical Trial Design and Analysis. R Package Version 2.0.4. 2022. Available from: https://CRAN.R-project.org/package=rpact [Last accessed: June12, 2022].
36.
JessM, TimmH, DieperinkKB. Video consultations in palliative care: A systematic integrative review. Palliat Med, 2019; 33(8):942–958; doi: 10.1177/0269216319854938
37.
WidbergC, WiklundB, KlarareA. Patients' experiences of eHealth in palliative care: An integrative review. BMC Palliat Care, 2020; 19(1):158; doi: 10.1186/s12904-020-00667-1
38.
BückmannA, BernhardtF, EveslageM, et al.Telemedical consultations in palliative care: Benefits through Knowledge Exchange and Intercollegiate Collaboration—Findings from the German oVID Project. Cancers, 2023; 15(9):2512.
39.
EbneterAS, SauterTC, ChristenA, et al.Feasibility, acceptability and needs in telemedicine for palliative care. Swiss Med Wkly, 2022; 152(9–10); doi: 10.4414/smw.2022.w30148
40.
BandiniJI, ScherlingA, FarmerC, et al.Experiences with telehealth for outpatient palliative care: Findings from a Mixed-Methods Study of Patients and Providers across the United States. J Palliat Med, 2022; 25(7):1079–1087; doi: 10.1089/jpm.2021.0545
41.
HoekPD, SchersHJ, BronkhorstEM, et al.The effect of weekly specialist palliative care teleconsultations in patients with advanced cancer—A randomized clinical trial. BMC Med, 2017; 15(1):119; doi: 10.1186/s12916-017-0866-9
42.
Hayes BauerE, Ørsted SchultzAN, BrinkA, et al.Patients' and Relatives' Preferences for a Palliative/Oncology Day Ward and Out-of-Hours Telemedicine-An Interpretive Description. Healthcare (Basel). 2021; 9(6):758; doi: 10.3390/healthcare9060758
43.
CrockettC, PriceJ, PhamM, et al.Experience with the routine use of electronic patient-reported outcome measures for patients with lung cancer. JCO Clin Cancer Inform, 2023; 7:e2200150; doi: 10.1200/cci.22.00150
44.
ConsoloL, CastelliniG, CilluffoS, et al.Electronic patient-reported outcomes (e-PROMs) in palliative cancer care: A scoping review. J Patient Rep Outcomes, 2022; 6(1):102; doi: 10.1186/s41687-022-00509-z
45.
KaramanidouC, NatsiavasP, KoumakisL, et al.Electronic patient-reported outcome-based interventions for palliative cancer care: A systematic and mapping review. JCO Clin Cancer Inform, 2020; 4:647–656; doi: 10.1200/cci.20.00015
46.
BenzeG, NauckF, Alt-EppingB, et al.PROutine: A feasibility study assessing surveillance of electronic patient reported outcomes and adherence via smartphone app in advanced cancer. Ann Palliat Med, 2019; 8(2):104–111; doi: 10.21037/apm.2017.07.05
47.
GaertnerJ, ElsnerF, Pollmann-DahmenK, et al.Electronic pain diary: A randomized crossover study. J Pain Symptom Manage, 2004; 28(3):259–267; doi: 10.1016/j.jpainsymman.2003.12.017
48.
KnappA, HarstL, HagerS, et al.Use of patient-reported outcome measures and patient-reported experience measures within evaluation studies of telemedicine applications: Systematic review. J Med Internet Res, 2021; 23(11):e30042; doi: 10.2196/30042
49.
RainsfordS, MacLeodRD, GlasgowNJ, et al.Rural end-of-life care from the experiences and perspectives of patients and family caregivers: A systematic literature review. Palliat Med, 2017; 31(10):895–912; doi: 10.1177/0269216316685234
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
